Witnessing Advances in Management Options for Patients With Early-Stage Non–Small Cell Lung Cancer

Kristin A. Higgins, MD

January 30, 2023

Kristin A. Higgins, MD, recalls the lack of curative treatment options for patients who were not candidates for surgical resection and how the treatment landscape has changed for this patient population.

Now, with curative treatment options available with stereotactic body radiation therapy (SBRT) and with the immunotherapy after SBRT options currently being studied, Dr Higgins sees major improvements on the horizon in terms of survivability for patients with early-stage NSCLC.

Any views expressed above are the author's own and do not necessarily reflect the views of WebMD or Medscape.

Cite this: Witnessing Advances in Management Options for Patients With Early-Stage Non–Small Cell Lung Cancer - Medscape - Jan 30, 2023.

Comments

Commenting is limited to medical professionals. To comment please Log-in.

Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.